QQ客服 官方微博 反馈留言

	Association between phosphodiesterase type 5 inhibitors use and risk of melanoma: a meta-analysis
	Deng, T.[1,2,3]; Duan, X.[1,2,3]; Liu, B.[4]; Lan, Y.[1,2,3]; Cai, C.[1,2,3]; Zhang, T.[1,2,3]; Zhu, W.[1,2,3]; Mai, Z.[1,2,3]; Wu, W.[1,2,3]; Zeng, G.[1,2,3]
	2018
卷号	65期号:2页码:216
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4756318
专题	暨南大学
作者单位	1.[1]Guangzhou Med Univ, Minimally Invas Surg Ctr, Dept Urol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China 2.[2]Guangzhou Inst Urol, Guangzhou, Guangdong, Peoples R China 3.[3]Guangdong Key Lab Urol, Guangzhou, Guangdong, Peoples R China 4.[4]Jinan Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Deng, T.[1,2,3],Duan, X.[1,2,3],Liu, B.[4],et al. Association between phosphodiesterase type 5 inhibitors use and risk of melanoma: a meta-analysis[J],2018,65(2):216.
APA	Deng, T.[1,2,3].,Duan, X.[1,2,3].,Liu, B.[4].,Lan, Y.[1,2,3].,Cai, C.[1,2,3].,...&Zeng, G.[1,2,3].(2018).Association between phosphodiesterase type 5 inhibitors use and risk of melanoma: a meta-analysis.,65(2),216.
MLA	Deng, T.[1,2,3],et al."Association between phosphodiesterase type 5 inhibitors use and risk of melanoma: a meta-analysis".65.2(2018):216.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。